Abstract
Currently, few efficient therapies are available to battle pancreatic cancer. Mechanisms underlying this cancer are not well known and researchers are trying to identify new therapeutic targets. Here, we present a review of new treatments and their results in recent years.
Keywords: Angiogenesis, hedgehog- JAK-STAT – notch, immunotherapy, pancreatic cancer, stroma, target therapies.
Graphical Abstract
Reviews on Recent Clinical Trials
Title:Pancreatic Cancer: Promises and Failures of Target Therapies
Volume: 11 Issue: 1
Author(s): Francesca Aroldi, Paola Bertocchi, Edoardo Rosso, Tiziana Prochilo and Alberto Zaniboni
Affiliation:
Keywords: Angiogenesis, hedgehog- JAK-STAT – notch, immunotherapy, pancreatic cancer, stroma, target therapies.
Abstract: Currently, few efficient therapies are available to battle pancreatic cancer. Mechanisms underlying this cancer are not well known and researchers are trying to identify new therapeutic targets. Here, we present a review of new treatments and their results in recent years.
Export Options
About this article
Cite this article as:
Aroldi Francesca, Bertocchi Paola, Rosso Edoardo, Prochilo Tiziana and Zaniboni Alberto, Pancreatic Cancer: Promises and Failures of Target Therapies, Reviews on Recent Clinical Trials 2016; 11 (1) . https://dx.doi.org/10.2174/1574887110666150930122720
DOI https://dx.doi.org/10.2174/1574887110666150930122720 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Disposition of Flavonoids Impacts their Efficacy and Safety
Current Drug Metabolism Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
Current Pharmaceutical Design Carbon Monoxide and the Pancreas
Current Pharmaceutical Biotechnology Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers
Current Cancer Therapy Reviews Effect of Antioxidant Extract from Cherries on Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature
Current Medicinal Chemistry A Review of the Effects of Gold, Silver, Selenium, and Zinc Nanoparticles on Diabetes Mellitus in Murine Models
Mini-Reviews in Medicinal Chemistry Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design Cancer Gene Therapy by Adenovirus-Mediated Gene Transfer
Current Gene Therapy Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Immunity to Tumour Antigens
Current Pharmaceutical Design Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design Generation, Subsets and Functions of Inducible Regulatory T Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?
Current Drug Targets Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Current Medicinal Chemistry Molecular Targets of FTY720 (Fingolimod)
Current Molecular Medicine Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Targeting Gender Difference in the Introduction of New Drugs for Diabetes Mellitus and Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?
Current Genomics Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
Current Medicinal Chemistry